<DOC>
	<DOC>NCT02453035</DOC>
	<brief_summary>The X-Pand Registry is intended to facilitate analysis of acute &amp; long-term safety as well as treatment outcomes with DESolve in patients with CAD.</brief_summary>
	<brief_title>DESolveÂ® X-Pand Global Post Market Registry</brief_title>
	<detailed_description>The Xpand Registry is a single-arm, multi-center, clinical Follow up study of patients with significant coronary stenosis who are treated with a commercially available DESolve Scaffold. The Registry is an observational study. The patients should be treated according to the current DESolve IFU, professional societies guidelines &amp; internal hospital guidelines.</detailed_description>
	<mesh_term>Coronary Stenosis</mesh_term>
	<criteria>1. Minimal age 18 years 2. Patient is willing/able to cooperate with study procedures and required follow up visits. Patient or legal representative has been informed &amp; agrees by signing EC approved written consent. Consent can occur before implantation of the DESolve scaffold (planned procedure) or within 30 days post implantation procedure for retrospective enrollment (unplanned procedure). 3. Planned or unplanned DESolve scaffold implantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>bioresorbable scaffold</keyword>
	<keyword>CAD</keyword>
</DOC>